Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 2
1962 5
1963 3
1964 4
1967 2
1968 4
1969 3
1970 4
1971 1
1972 7
1973 1
1974 1
1975 5
1976 2
1977 7
1978 16
1979 13
1980 18
1981 20
1982 14
1983 16
1984 8
1985 15
1986 9
1987 18
1988 20
1989 32
1990 35
1991 33
1992 21
1993 45
1994 51
1995 57
1996 81
1997 71
1998 101
1999 129
2000 152
2001 174
2002 254
2003 318
2004 309
2005 374
2006 415
2007 548
2008 670
2009 760
2010 896
2011 1014
2012 1093
2013 1272
2014 1381
2015 1472
2016 1561
2017 1495
2018 1441
2019 1434
2020 1654
2021 1888
2022 1779
2023 1690
2024 709

Text availability

Article attribute

Article type

Publication date

Search Results

22,712 results

Results by year

Filters applied: . Clear all
Page 1
Omalizumab for the Treatment of Multiple Food Allergies.
Wood RA, Togias A, Sicherer SH, Shreffler WG, Kim EH, Jones SM, Leung DYM, Vickery BP, Bird JA, Spergel JM, Iqbal A, Olsson J, Ligueros-Saylan M, Uddin A, Calatroni A, Huckabee CM, Rogers NH, Yovetich N, Dantzer J, Mudd K, Wang J, Groetch M, Pyle D, Keet CA, Kulis M, Sindher SB, Long A, Scurlock AM, Lanser BJ, Lee T, Parrish C, Brown-Whitehorn T, Spergel AKR, Veri M, Hamrah SD, Brittain E, Poyser J, Wheatley LM, Chinthrajah RS. Wood RA, et al. Among authors: kim eh. N Engl J Med. 2024 Mar 7;390(10):889-899. doi: 10.1056/NEJMoa2312382. Epub 2024 Feb 25. N Engl J Med. 2024. PMID: 38407394 Clinical Trial.
Nav1.7 as a chondrocyte regulator and therapeutic target for osteoarthritis.
Fu W, Vasylyev D, Bi Y, Zhang M, Sun G, Khleborodova A, Huang G, Zhao L, Zhou R, Li Y, Liu S, Cai X, He W, Cui M, Zhao X, Hettinghouse A, Good J, Kim E, Strauss E, Leucht P, Schwarzkopf R, Guo EX, Samuels J, Hu W, Attur M, Waxman SG, Liu CJ. Fu W, et al. Among authors: kim e. Nature. 2024 Jan;625(7995):557-565. doi: 10.1038/s41586-023-06888-7. Epub 2024 Jan 3. Nature. 2024. PMID: 38172636 Free PMC article.
Kim E. Kim E. Palliat Support Care. 2024 Jan 22:1. doi: 10.1017/S1478951523001967. Online ahead of print. Palliat Support Care. 2024. PMID: 38251429 No abstract available.
Kim E. Kim E. J Gen Intern Med. 2024 Feb 5. doi: 10.1007/s11606-024-08665-2. Online ahead of print. J Gen Intern Med. 2024. PMID: 38315410 No abstract available.
Atopic dermatitis (eczema) guidelines: 2023 American Academy of Allergy, Asthma and Immunology/American College of Allergy, Asthma and Immunology Joint Task Force on Practice Parameters GRADE- and Institute of Medicine-based recommendations.
AAAAI/ACAAI JTF Atopic Dermatitis Guideline Panel; Chu DK, Schneider L, Asiniwasis RN, Boguniewicz M, De Benedetto A, Ellison K, Frazier WT, Greenhawt M, Huynh J, Kim E, LeBovidge J, Lind ML, Lio P, Martin SA, O'Brien M, Ong PY, Silverberg JI, Spergel JM, Wang J, Wheeler KE, Guyatt GH; Patient Groups: Global Parents for Eczema Research; Capozza K; National Eczema Association; Begolka WS; Evidence in Allergy Group; Chu AWL, Zhao IX, Chen L, Oykhman P, Bakaa L; AAAAI/ACAAI Joint Task Force on Practice Parameters; Golden D, Shaker M, Bernstein JA, Greenhawt M, Horner CC, Lieberman J, Stukus D, Rank MA, Wang J, Ellis A, Abrams E, Ledford D, Chu DK. AAAAI/ACAAI JTF Atopic Dermatitis Guideline Panel, et al. Among authors: kim e. Ann Allergy Asthma Immunol. 2024 Mar;132(3):274-312. doi: 10.1016/j.anai.2023.11.009. Epub 2023 Dec 18. Ann Allergy Asthma Immunol. 2024. PMID: 38108679
Editorial Overview: Molecular neuroscience.
Yu X, Kim E. Yu X, et al. Among authors: kim e. Curr Opin Neurobiol. 2024 Apr 1;86:102873. doi: 10.1016/j.conb.2024.102873. Online ahead of print. Curr Opin Neurobiol. 2024. PMID: 38564830 No abstract available.
A single-cell atlas of IL-23 inhibition in cutaneous psoriasis distinguishes clinical response.
Wu D, Hailer AA, Wang S, Yuan M, Chan J, El Kurdi A, Han D, Ali H, D'Angio B, Mayer A, Rahim M, Kondo A, Klufas D, Kim E, Shain AH, Choi J, Bhutani T, Simpson G, Grekin RC, Ricardo-Gonzalez R, Purdom E, North JP, Cheng JB, Cho RJ. Wu D, et al. Among authors: kim e. Sci Immunol. 2024 Jan 26;9(91):eadi2848. doi: 10.1126/sciimmunol.adi2848. Epub 2024 Jan 26. Sci Immunol. 2024. PMID: 38277466
Sotorasib with panitumumab in chemotherapy-refractory KRASG12C-mutated colorectal cancer: a phase 1b trial.
Kuboki Y, Fakih M, Strickler J, Yaeger R, Masuishi T, Kim EJ, Bestvina CM, Kopetz S, Falchook GS, Langer C, Krauss J, Puri S, Cardona P, Chan E, Varrieur T, Mukundan L, Anderson A, Tran Q, Hong DS. Kuboki Y, et al. Among authors: kim ej. Nat Med. 2024 Jan;30(1):265-270. doi: 10.1038/s41591-023-02717-6. Epub 2024 Jan 4. Nat Med. 2024. PMID: 38177853 Clinical Trial.
Adeno-to-squamous transition drives resistance to KRAS inhibition in LKB1 mutant lung cancer.
Tong X, Patel AS, Kim E, Li H, Chen Y, Li S, Liu S, Dilly J, Kapner KS, Zhang N, Xue Y, Hover L, Mukhopadhyay S, Sherman F, Myndzar K, Sahu P, Gao Y, Li F, Li F, Fang Z, Jin Y, Gao J, Shi M, Sinha S, Chen L, Chen Y, Kheoh T, Yang W, Yanai I, Moreira AL, Velcheti V, Neel BG, Hu L, Christensen JG, Olson P, Gao D, Zhang MQ, Aguirre AJ, Wong KK, Ji H. Tong X, et al. Among authors: kim e. Cancer Cell. 2024 Mar 11;42(3):413-428.e7. doi: 10.1016/j.ccell.2024.01.012. Epub 2024 Feb 22. Cancer Cell. 2024. PMID: 38402609 Free article.
22,712 results
You have reached the last available page of results. Please see the User Guide for more information.